RA

Roni Ashuri

Active Director Director DIN 09831305
DIN 09831305 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Roni Ashuri

Data last updated:

Roni Ashuri is a Director at Proteantecs India Private Limited (since 2022). The company operates in Healthcare. Proteantecs India Private Limited reported revenue of ₹18.13 Cr (FY 2025).

DIN 09831305
Primary Designation Director
Industry Healthcare
First Appointment 20 Dec 2022
Oldest Company Age 5 yrs
Largest company Proteantecs India Private Limited · ₹18.13 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Proteantecs India Private Limited U74999PN2021FTC202479
Director20 Dec 20222021₹18.13 Cr (FY 2025)Active

Board colleagues of Roni Ashuri

Directorship timeline

Open interactive timeline →
Proteantecs India Private Limited
Premium access

Shareholding and investment profile for Roni Ashuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roni Ashuri

Roni Ashuri currently holds 1 directorship: Proteantecs India Private Limited (Director, since 20 Dec 2022, revenue ₹18.13 Cr (FY 2025)).

Roni Ashuri was first appointed on 20 Dec 2022 as Director at Proteantecs India Private Limited.

The current boards of Roni Ashuri's companies include Eran Nune Ben Horin (Proteantecs India Private Limited), Vijaykishan Narayanan (Proteantecs India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available